Rhythm Biosciences (ASX:RHY) Net Income (Continuing Operations) : A$-8.63 Mil (TTM As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Rhythm Biosciences Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Rhythm Biosciences's Net Income (Continuing Operations) for the six months ended in Dec. 2023 was A$-4.09 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-8.63 Mil.

Rhythm Biosciences Net Income (Continuing Operations) Historical Data

The historical data trend for Rhythm Biosciences's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Biosciences Net Income (Continuing Operations) Chart

Rhythm Biosciences Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Net Income (Continuing Operations)

Get a 7-Day Free Trial

-2.55

-4.02

-6.61

-8.79

-8.22

Rhythm Biosciences Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Income (Continuing Operations)	Get a 7-Day Free Trial								-4.22	-4.57	-3.68	-4.54	-4.09

Rhythm Biosciences Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-8.63 Mil.

Rhythm Biosciences (ASX:RHY) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Rhythm Biosciences Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Rhythm Biosciences's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhythm Biosciences (ASX:RHY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rhythm Biosciences Ltd (ASX:RHY) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

0RY:Germany

Address

30 Flemington Road, Bio21 Institute, Parkville, Melbourne, VIC, AUS, 3010

Website

https://www.rhythmbio.com

Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. Geographically, the company operates only in Australia.

Rhythm Biosciences (ASX:RHY) Headlines

No Headlines